eCOA and ePRO for Oncology Trials

Oncology research doesn’t move in straight lines. Cycles shift. Doses change. Symptoms evolve. Patients face uncertainty on a daily basis. And every moment in their journey requires technology that can adapt instantly with clarity, compassion, and absolute reliability. Datacubed was built for this reality.

Our cycle-based architecture and patient-centered experience give oncology sponsors, CROs, sites, and most importantly patients, a platform that finally fits the way oncology trials actually run: nonlinear, nuanced, and deeply human. This is oncology eCOA and ePRO reimagined from the ground up.

Built Around the True Oncology Trial Life Cycle

Most clinical research technology forces oncology into a rigid visit-based model that breaks the moment real life intervenes. Oncology doesn’t work that way, and neither do we. Datacubed is engineered around cycles, the real heartbeat of oncology trials. When a dose changes, a visit is added, or an adverse event requires a pause, the platform adapts in real time without rebuilds, delays, or disruption.

A platform shaped around oncology reality provides:

  • Cycle-based study design aligned with complex dosing and shifting response timelines
  • Instant flexibility for individualized treatment plans
  • Seamless adjustments for unplanned visits, delays, or treatment interruptions
  • Unified dashboards providing real-time visibility into cycle progress, compliance trends, and emerging safety signals
  • Configurable workflows that scale effortlessly across multi-arm, global oncology studies

Designed for the Patients Who Live the Journey

Cancer patients navigate side effects, fatigue, fear, and information overload. Technology must reduce this burden, not add to it. Datacubed creates an experience that meets patients with clarity and empathy. Every screen, every reminder, every task is intentionally designed to be simple, comforting, and easy to complete, even on the hardest days.

Benefits include:

  • A clean, intuitive app experience adapted to patient capabilities
  • Configurable symptom and side-effect tracking aligned with protocol requirements
  • Clear visibility into cycle milestones, upcoming visits, and required tasks
  • Built-in reminders that guide patients gently — not overwhelm them
  • Multilingual, multicultural support for diverse global populations

Clarity and Control for Sites and Sponsors

Oncology study teams operate in a world of intense urgency and precision. Safety signals must be visible immediately. Treatment changes must sync across every workflow, and deviations can’t wait for manual reconciliation. Datacubed gives sites, sponsors, and CROs a unified operational picture of every patient, every cycle, and every arm in real time.

Built for the operational demands of oncology:

  • Centralized cycle-based dashboards
  • Real-time alerts for missed tasks, delayed doses, or safety-triggering symptoms
  • Patient-level and study-level insights that surface early warning signs
  • Seamless tracking across dose holds, dose reductions, and treatment modifications
  • An audit-ready, compliance-first framework engineered for global oncology requirements

Experience the Future of Oncology eCOA and ePRO

Oncology trials are some of the most difficult and meaningful work in clinical research. They require tools that don’t just collect data but elevate clarity, reduce burden, and adapt to the unexpected with grace. See how Datacubed elevates the standard.

Contact Us

  • “I liked Datacubed because of the ease of use, and the fact that I could do the questions at a speed I felt comfortable with.”

    Usability Test Patient

  • “Datacubed continues to ask questions and involve sites and not only hears the feedback but implements changes to its product continually.”

    Karri Venn
    COO, Centricity Research

  • “They have not only embraced the needs of our study, but they have taken it upon themselves to identify ways to make their system more efficient, patient-friendly, and study appropriate.”

    Anonymous Sponsor
    MPH, VP, Program Manager & Clinical Operations, Clinical Trial Sponsor

  • “Overall, it’s been very positive, and sites are very excited to use our system!”

    Anonymous Sponsor
    Clinical Research Study Team, Academic Medical School

  • “We are using the geofencing technology for patients experiencing an infection that would typically result in an emergency care visit. By targeting facilities with an emergency department, we believe we will be able to track at least 95 percent of the medical visits brought on by the infection.”

    Anonymous Sponsor
    Director, Clinical Innovation, Top 10 Pharma

  • “In comparison to other eCOA developers, the Datacubed Health solution provides our study team with the flexibility, cost savings, and improved patient engagement of using the patient’s personal handheld device and provides the study team with real time access to patient responses and analytics.”

    Anonymous Sponsor
    Director, Clinical Development, Clinical Team Lead, Neurology and Ophthalmology Pharma

  • “The Admin Panel is quite intuitive, and development was simple.”

    Anonymous Sponsor
    Founder, CEO, Nutraceutical Company

  • “The Datacubed Health platform is really nice to look at and is intuitive for technology competency. It’s very pleasing to our international network.”

    Anonymous Sponsor
    Clinical Coordinator, Rare Disease, Alzheimers, Network Academic Medical Center

  • “The study represents one of the most important opportunities to understand Alzheimer’s disease. We are excited to partner with Datacubed Health in order to bring a new set of tools to interact with our participants and collect information outside of the typical research environment.”

    Anonymous Sponsor
    Principal Investigator, Academic Medical Center

  • “The gamification was a unique selling point for me. Also, having the opportunity to have a possibility if needed to discuss medical issues outside of the clinical team. Having someone from the medical team who could give insights and perspectives on oncology in particular.”

    Anonymous Sponsor
    Director, Clinical Innovation, Top 10 Pharma